Analysis of the factors of survival to renal replacement therapy in patients with chronic kidney disease
Journal Title: Нирки - Year 2018, Vol 7, Issue 3
Abstract
Background. The relationship between chronic kidney disease (CKD) and cardiovascular diseases is important and is characterized by the presence of numerous adverse factors compared with patients with cardiovascular disease alone. The purpose of the study is to evaluate the incidence of risk factors for cardiovascular complications, nephrological risk factors and their combination in patients with CKD stage IV–V, who survived to the stage of renal replacement therapy. Materials and methods. Retrospectively, we have analyzed medical records (for 2 years) of 42 patients (12 (28.6 %) men, 30 (71.4 %) women) with CKD stage IV–V, who by the time of medical records analysis did not receive renal replacement therapy. All patients underwent the following measurements: body mass index, blood pressure, heart rate, complete blood count and biochemical blood test, the level of residual diuresis. To determine glomerular filtration rate (GFR), we used Chronic Kidney Disease Epidemiology Collaboration equation. Statistical processing of research materials was performed by means of Statistica v. 6.1 software package (Statsoft Inc., USA). Results. The mean age of patients was 47.6 ± 11.6 years. The study showed that patients with CKD, who survived to renal replacement therapy, had daily diuresis more than 500 ml, heart rate less than 90 bpm. Systolic blood pressure in such patients was maintained with drugs at the level of not less than 160 mmHg. The level of total cholesterol more than 4.5 mmol/l and body mass index more than 25 kg/m2 were also characteristic features. We found a direct correlation between GFR and total cholesterol (r = 0.32, p = 0.04), GFR and hemoglobin (r = 0.39, p = 0.01) and a direct correlation between GFR and the amount of residual urine (r = 0.32, p = 0.04). Conclusions. The most significant factors of survival of a patient with CKD before renal replacement therapy are: young age (under 40 years), presence of residual urine (daily diuresis more than 500 ml/day), absence of diabetes mellitus. The control of anemia and systolic blood pressure < 160 mmHg are of particular importance.
Authors and Affiliations
O. V. Kuryata, Ye. O. Frolova, T. D. Yashenko
Keywords
Related Articles
- EP ID EP369493
- DOI 10.22141/2307-1257.7.3.2018.140198
- Views 61
- Downloads 0
Endothelial dysfunction in the pathogenesis of diabetic kidney disease
The article deals with the integrated characteristics of hyperglycemia role in the pathogenesis of vascular complications of diabetes mellitus. The article analyzes the modern data on the mechanisms of development and pr...
Antibiotic resistance and vaccination in patients with urinary tract infection
Limited in experience of using uroantiseptics, even those manufactured in European countries, such as Furamag and Macmiror, excessive use of antibiotics, which causes antibiotic resistance in the EU countries and form re...
Influence of phytotherapy on metabolic status and urine microbiota in patients with urolithiasis — calcium oxalate nephrolithiasis after shock wave lithotripsy
Background. The study of the problem of urolithiasis in recent years has reached a qualitatively new level in connection with the use of a multidisciplinary approach and the principles of evidence-based medicine. In the...
Pathophysiological and Methodological Aspects of Determining Renal Functional Reserve in Clinical Nephrology
The article pathogenetically substantiates the feasibility of using methods for determining functional renal reserve through salt and water loading of 0.5% sodium chloride in an amount of 0.5 % of the body weight in pati...
Clinical practice guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR < 45 ml/min/1.73 m2) European renal best practice
.